FindTrial
Sign In

Efficacy of furosemide for prevention of volume overload in children with transfusion-dependent thalassemia at Phramongkutklao hospital

Efficacy of furosemide for prevention of volume overload in children with transfusion-dependent thalassemia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180209001
Enrollment
20
Registered
2018-02-09
Start date
2018-02-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

undrelying thalassemia who receive blood transfusion transfusion&#44

Interventions

give before or after to monitor outcome
Active Comparator Drug
furosemide

Sponsors

phramongkutklao hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1.age 1-25 yrs. 2.need transfusin dependent 3.parental permission

Exclusion criteria

Exclusion criteria: 1.history of allergic to furosemide 2. history of heart failure 3.history of high blood pressure

Design outcomes

Primary

MeasureTime frame
NT-proBNP 4 hrs ug/dl—

Secondary

MeasureTime frame
blood pressure 4 hrs mmhg—

Countries

thailand

Contacts

Public Contactchanchai traivaree

Phramongkutklao Hospital

ctrivaree@yahoo.com0817556677

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026